Loxapine Inahlation Powder

Form: Inhalation Powder (single-use oral inhaler)

Strength: 10 mg

Reference Brands: Adasuve®(US & EU)

Category: Antipsychotropic Drugs

Loxapine inhalation powder is FDA-approved in the U.S. under the brand Adasuve for the acute treatment of agitation associated with schizophrenia and bipolar I disorder. In the EU, it is authorized under EMA regulation with Risk Evaluation and Mitigation Strategy (REMS) and mandatory pulmonary function monitoring due to bronchospasm risk. Regulatory submissions must include clinical safety data, device compatibility, and GMP compliance for combination drug-device products. For global buyers and distributors seeking dossier-ready forms of Loxapine inhalation powder or other delivery formats, visit Pharmatradz.com — your B2B gateway to trusted pharmaceutical manufacturers and suppliers.